Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
J Med Microbiol. 2018 Jul;67(7):976-981. doi: 10.1099/jmm.0.000774.
Increasing evidence suggests that asymptomatic carriers are an important source of healthcare-associated infection. However, it is not known which test for the detection of colonization is most sensitive in patients with haematological malignancies. We performed a prospective cohort study of 101 patients with haematological malignancies who had been admitted to the hospital for scheduled chemotherapy or haematopoietic cell transplantation. Each patient provided a formed stool sample. We compared the performance of five different commercially available assays, using toxigenic culture as the reference method. The prevalence of toxigenic colonization as determined by toxigenic culture was 14/101 (14 %). The Cepheid Xpert PCR /Epi was the most sensitive test for the detection of toxigenic colonization, with 93 % sensitivity and 99 % negative predictive value. Our findings suggest that the Xpert PCR /Epi could be used to rule out toxigenic colonization in this population.
越来越多的证据表明,无症状携带者是医疗保健相关感染的重要传染源。然而,目前尚不清楚在血液恶性肿瘤患者中,哪种检测定植的方法最敏感。我们对 101 例因计划化疗或造血细胞移植而住院的血液恶性肿瘤患者进行了前瞻性队列研究。每位患者均提供了成型粪便样本。我们比较了五种不同的市售检测方法的性能,以产毒培养作为参考方法。产毒培养确定的产毒定植的患病率为 14/101(14%)。Cepheid Xpert PCR/Epi 是检测产毒定植最敏感的检测方法,其灵敏度为 93%,阴性预测值为 99%。我们的研究结果表明,Xpert PCR/Epi 可用于排除该人群中的产毒定植。